ClinConnect ClinConnect Logo
Search / Trial NCT05804240

TEE 3D RV Assessment for SAVR, Mini AVR, and TAVR

Launched by THOMAS JEFFERSON UNIVERSITY · Apr 6, 2023

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Right Ventricular Dysfunction Three Dimensional Transesophageal Echocardiography Surgical Aortic Valve Replacement Mini Sternotomy Aortic Valve Replacement Transcatheter Aortic Valve Replacement

ClinConnect Summary

This clinical trial is exploring how well a special imaging technique called three-dimensional echocardiography can assess the function of the right side of the heart (called the right ventricle) in patients who have had different types of aortic valve replacement surgeries. Specifically, the study is looking at three methods: traditional surgical aortic valve replacement (SAVR), a less invasive option called mini-sternotomy aortic valve replacement (mini AVR), and a newer procedure known as transcatheter aortic valve replacement (TAVR). By using this advanced imaging, researchers hope to better understand how these surgeries affect heart function.

To participate in this trial, individuals need to be adults over 18 years old who have undergone one of the three types of valve replacement surgery mentioned. The study is currently recruiting participants of all genders. If you decide to join, you can expect to undergo some imaging tests to evaluate your heart's function. It's important to note that if the imaging results are not clear enough, or if you choose not to participate, you may not be included in the study. This research aims to improve care for patients with right ventricular dysfunction, helping doctors make better decisions in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients over 18 years old
  • Patients who had SAVR, mini AVR, or TAVR
  • Exclusion criteria:
  • Patients' refusal
  • Suboptimal echocardiography data for RVEF, RV size, RIMP, RVFAC, TAPSE, S', STE

About Thomas Jefferson University

Thomas Jefferson University is a distinguished academic institution located in Philadelphia, Pennsylvania, renowned for its commitment to advancing healthcare through research and education. As a clinical trial sponsor, the university leverages its extensive resources and interdisciplinary expertise to conduct innovative research aimed at improving patient outcomes. With a focus on translational medicine, Thomas Jefferson University collaborates with various stakeholders, including healthcare professionals, industry partners, and regulatory agencies, to ensure the highest standards of scientific rigor and ethical conduct in its clinical trials. The institution is dedicated to fostering a culture of excellence in research, ultimately contributing to the advancement of medical knowledge and the development of novel therapeutic interventions.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Yoshihisa Morita, MD

Principal Investigator

Thomas Jefferson University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials